- Home
- Companies
- MedChemExpress LLC (MCE)
- Products
- MedChemExpress - Model ...
MedChemExpress - Model Methylprednisolone aceponate -86401-95-8
Methylprednisolone aceponate (ZK 91588) is a glucocorticoid and anti-inflammatory agent with weak systemic effects. Methylprednisolone aceponate is a selective glucocorticoid receptor Ligand.Methylprednisolone aceponate can be used for research of eczema and other inflammatory skin disorders[1][2][3].MCE products for research use only. We do not sell to patients.
Methylprednisolone aceponate
MCE China:Methylprednisolone aceponate
Brand:MedChemExpress (MCE)
Cat. No.HY-103025
CAS:86401-95-8
Synonyms:ZK 91588; MPA
Purity:99.44%
Storage:Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Shipping:Room temperature in continental US; may vary elsewhere.
Description:Methylprednisolone aceponate (ZK 91588) is a glucocorticoid and anti-inflammatory agent with weak systemic effects. Methylprednisolone aceponate is a selective glucocorticoid receptor Ligand.Methylprednisolone aceponate can be used for research of eczema and other inflammatory skin disorders.
In Vitro:Methylprednisolone aceponate inhibits collagenase promoter activity (in HeLa cells), LPS-induced IL-12p40 secretion (in human PBMCs) and phytohemagglutinin-induced IFN-γ secretion (in human PBMCs) with IC50s of 9.3, 16.8, 15.2 nM[3]. Methylprednisolone aceponate induces MMTV promoter and TAT activities with EC50s of 21.8 and 20.5 nM respectively[3].
In Vivo:Methylprednisolone aceponate (topically applied, 50 μL,,Coroton oil-induced Evan blue edema) shows anti-inflammatory effect with an IC50 of 0.0015%, with low systemic side effect[1]. Methylprednisolone aceponate (0.0001%-0.1%, topically applied) inhibits oedema formation with ED50 of 0.002% in irritant contact dermatitis in mice and rat[3].
Hot selling product:Enasidenib | Liothyronine (sodium) | Phorbol 12,13-dibutyrate | Oseltamivir (phosphate) | C14-4 | Salcaprozate (sodium) | YM-201636 | HTH-01-015 | Azaserine | Cycloastragenol
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
References:
[1]. Ruzicka T. Methylprednisolone aceponate in eczema and other inflammatory skin disorders -- a clinical update. Int J Clin Pract. 2006 Jan;60(1):85-92. [Content Brief]
[3]. Schäcke H, et al. Characterization of ZK 245186, a novel, selective glucocorticoid receptor agonist for the topical treatment of inflammatory skin diseases. Br J Pharmacol. 2009 Oct;158(4):1088-103. [Content Brief]
Brand introduction:
• MCE (MedChemExpress) has a global exclusive compound library of more than 200 kinds, and we are committed to providing the most comprehensive range of high-quality small molecule active compounds for scientific research customers around the world;
• More than 50,000 highly selective inhibitors and agonists are involved in various popular signaling pathways and disease areas;
• The products cover a variety of recombinant proteins, peptides, commonly used kits, more PROTAC, ADC and other characteristic products, widely used in new drug research and development, life science and other scientific research projects;
• Provide virtual screening, ion channel screening, metabolomics analysis detection analysis, drug screening and other professional technical services;
• It has a professional experimental center and strict quality control and verification system;
• Provide LC/MS, NMR, HPLC, chiral analysis, elemental analysis and other quality inspection reports to ensure the high purity and high quality of products;
• The biological activity of the products has been verified by the experiments of customers in various countries;
• A variety of top journals such as Nature, Cell, Science and pharmaceutical patents have included the scientific research results of MCE customers;
• Our professional team tracks the latest pharmaceutical and life science research and provides you with the latest active compounds in the world;
• It has established long-term cooperation with the world's major pharmaceutical companies and well-known scientific research institutions。
